NeuroPace, Inc. NPCE
12.31 USD -0.03 (-0.24%)
At closeNov 3, 2026, 4:01 PM EST
12.31 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
12.00 Day range 12.64
9.23 52-week range 19.60
- YTD
- -20.27%
- 1 year
- +30.96%
Financial health
Altman Z-Score
-3.77 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -23.4×
FY 2019 5y median -8.1× FY 2025
P/S 5.1×
FY 2019 5y median 4.1× FY 2025
P/B 26.5×
FY 2019 5y median 12.9× FY 2025
P/FCF -44.6×
FY 2019 5y median -13.4× FY 2025
EV/EBITDA -46.0×
FY 2019 5y median -14.1× FY 2025
EV/Sales 5.5×
FY 2019 5y median 4.8× FY 2025
FCF Yield -2.2%
FY 2019 5y median -7.5% FY 2025
Profitability
Gross Margin 77.2%
FY 2019 5y median 73.9% FY 2025
Operating Margin -16.3%
FY 2019 5y median -41.5% FY 2025
Net Margin -21.5%
FY 2019 5y median -50.4% FY 2025
ROE -112.8%
FY 2019 5y median -135.4% FY 2025
ROIC -18.2%
FY 2019 5y median -26.6% FY 2025
ROA -20.3%
FY 2019 5y median -28.7% FY 2025
Growth (YoY)
Revenue 25.1%
FY 2019 FY 2025
Operating Income 24.6%
FY 2019 FY 2025
EPS (diluted) 29.0%
FY 2019 FY 2025
Free Cash Flow 37.9%
FY 2019 FY 2025
Financial Health
Current Ratio 5.3×
FY 2019 5y median 5.7× FY 2025
Quick Ratio 4.3×
FY 2019 5y median 5.0× FY 2025
Debt / Equity 3.7×
FY 2019 5y median 3.5× FY 2025
Net Debt / EBITDA -4.1×
FY 2019 5y median -2.4× FY 2025
Interest Coverage -2.2×
FY 2019 5y median -3.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31